Intrinsic Value of S&P & Nasdaq Contact Us

Fate Therapeutics, Inc. FATE NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$39.50
+2847.8%

Fate Therapeutics, Inc. (FATE) has 12 identified peers for comparison in the Healthcare sector. Peers include ATRA, BEAM, BPMC, CRBU, CRSP, EDIT and others.

FATE has a market capitalization of $155.79M, compared to an average peer market cap of $2.16B. FATE is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message